BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 29 filers reported holding BIOLINERX LTD in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $21,000 | -16.0% | 57,000 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $25,000 | +66.7% | 57,000 | +67.6% | 0.01% | +16.7% |
| Q4 2018 | $15,000 | -61.5% | 34,000 | -5.6% | 0.01% | -53.8% |
| Q3 2018 | $39,000 | +21.9% | 36,000 | 0.0% | 0.01% | +8.3% |
| Q2 2018 | $32,000 | +3.2% | 36,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $31,000 | -20.5% | 36,000 | 0.0% | 0.01% | -25.0% |
| Q4 2017 | $39,000 | +11.4% | 36,000 | +16.1% | 0.02% | +14.3% |
| Q3 2017 | $35,000 | +34.6% | 31,000 | 0.0% | 0.01% | +40.0% |
| Q2 2017 | $26,000 | -13.3% | 31,000 | 0.0% | 0.01% | -16.7% |
| Q1 2017 | $30,000 | +30.4% | 31,000 | +24.0% | 0.01% | +20.0% |
| Q4 2016 | $23,000 | -11.5% | 25,000 | +8.7% | 0.01% | -9.1% |
| Q3 2016 | $26,000 | +30.0% | 23,000 | -8.0% | 0.01% | +22.2% |
| Q2 2016 | $20,000 | +5.3% | 25,000 | +100.0% | 0.01% | 0.0% |
| Q3 2015 | $19,000 | -42.4% | 12,500 | 0.0% | 0.01% | -30.8% |
| Q2 2015 | $33,000 | +3.1% | 12,500 | -16.7% | 0.01% | 0.0% |
| Q1 2015 | $32,000 | +100.0% | 15,000 | +50.0% | 0.01% | +116.7% |
| Q4 2014 | $16,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,451,000 | $3,236,000 | 2.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 600,000 | $1,338,000 | 0.30% |
| BVF INC/IL | 800,000 | $1,784,000 | 0.28% |
| Senvest Management, LLC | 1,549,805 | $3,456,000 | 0.27% |
| SABBY MANAGEMENT, LLC | 1,902,800 | $4,243,000 | 0.24% |
| Perceptive Advisors | 179,041 | $399,000 | 0.04% |
| Orbimed Advisors | 1,135,000 | $2,531,000 | 0.03% |
| Benchmark Capital Advisors | 20,000 | $45,000 | 0.03% |
| JANE STREET GROUP, LLC | 59,063 | $130,000 | 0.00% |
| Virtu KCG Holdings LLC | 18,640 | $41,000 | 0.00% |